119 related articles for article (PubMed ID: 35879101)
1. MORC3 restricts human cytomegalovirus infection by suppressing the major immediate-early promoter activity.
Ma XH; Yao YX; Wang XZ; Zhou YP; Huang SN; Li D; Mei MJ; Wu JP; Pan YT; Cheng S; Jiang X; Sun JY; Zeng WB; Gong S; Cheng H; Luo MH; Yang B
J Med Virol; 2022 Nov; 94(11):5492-5506. PubMed ID: 35879101
[TBL] [Abstract][Full Text] [Related]
2. MORC3 represses the HCMV major immediate early promoter in myeloid cells in the absence of PML nuclear bodies.
Champion A; Rowland A; Yee L; van den Boomen D; Reeves M; Lehner P; Sinclair J; Poole E
J Med Virol; 2023 Nov; 95(11):e29227. PubMed ID: 38009611
[TBL] [Abstract][Full Text] [Related]
3. MORC3, a Component of PML Nuclear Bodies, Has a Role in Restricting Herpes Simplex Virus 1 and Human Cytomegalovirus.
Sloan E; Orr A; Everett RD
J Virol; 2016 Oct; 90(19):8621-33. PubMed ID: 27440897
[TBL] [Abstract][Full Text] [Related]
4. Chromatin-Remodeling Factor SPOC1 Acts as a Cellular Restriction Factor against Human Cytomegalovirus by Repressing the Major Immediate Early Promoter.
Reichel A; Stilp AC; Scherer M; Reuter N; Lukassen S; Kasmapour B; Schreiner S; Cicin-Sain L; Winterpacht A; Stamminger T
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743358
[TBL] [Abstract][Full Text] [Related]
5. Expression of Human Cytomegalovirus IE1 Leads to Accumulation of Mono-SUMOylated PML That Is Protected from Degradation by Herpes Simplex Virus 1 ICP0.
Hou W; Cruz-Cosme R; Wen F; Ahn JH; Reeves I; Luo MH; Tang Q
J Virol; 2018 Dec; 92(23):. PubMed ID: 30258013
[TBL] [Abstract][Full Text] [Related]
6. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection.
Ahn JH; Hayward GS
Virology; 2000 Aug; 274(1):39-55. PubMed ID: 10936087
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Recombinant Human Cytomegaloviruses Encoding IE1 Mutants L174P and 1-382 Reveals that Viral Targeting of PML Bodies Perturbs both Intrinsic and Innate Immune Responses.
Scherer M; Otto V; Stump JD; Klingl S; Müller R; Reuter N; Muller YA; Sticht H; Stamminger T
J Virol; 2016 Feb; 90(3):1190-205. PubMed ID: 26559840
[TBL] [Abstract][Full Text] [Related]
8. The Human Cytomegalovirus IE1 Protein Antagonizes PML Nuclear Body-Mediated Intrinsic Immunity via the Inhibition of PML De Novo SUMOylation.
Schilling EM; Scherer M; Reuter N; Schweininger J; Muller YA; Stamminger T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903803
[TBL] [Abstract][Full Text] [Related]
9. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
J Virol; 2017 May; 91(10):. PubMed ID: 28250117
[TBL] [Abstract][Full Text] [Related]
10. Revisiting promyelocytic leukemia protein targeting by human cytomegalovirus immediate-early protein 1.
Paulus C; Harwardt T; Walter B; Marxreiter A; Zenger M; Reuschel E; Nevels MM
PLoS Pathog; 2020 May; 16(5):e1008537. PubMed ID: 32365141
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the functional interchange between the IE1 and pp71 proteins of human cytomegalovirus and ICP0 of herpes simplex virus 1.
Lu Y; Everett RD
J Virol; 2015 Mar; 89(6):3062-75. PubMed ID: 25552717
[TBL] [Abstract][Full Text] [Related]
12. Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus.
Kim YE; Ahn JH
PLoS Pathog; 2015 Mar; 11(3):e1004785. PubMed ID: 25812002
[TBL] [Abstract][Full Text] [Related]
13. RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions.
Xiaofei E; Stadler BM; Debatis M; Wang S; Lu S; Kowalik TF
J Virol; 2012 May; 86(10):5660-73. PubMed ID: 22438545
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of the Replication of ICP0-Null Mutant Herpes Simplex Virus 1 and pp71-Deficient Human Cytomegalovirus by Epstein-Barr Virus Tegument Protein BNRF1.
Lu Y; Orr A; Everett RD
J Virol; 2016 Nov; 90(21):9664-9673. PubMed ID: 27535048
[TBL] [Abstract][Full Text] [Related]
15. Promyelocytic Leukemia Protein Potently Restricts Human Cytomegalovirus Infection in Endothelial Cells.
Seitz S; Heusel AT; Stamminger T; Scherer M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233232
[TBL] [Abstract][Full Text] [Related]
16. The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10).
Ahn JH; Jang WJ; Hayward GS
J Virol; 1999 Dec; 73(12):10458-71. PubMed ID: 10559364
[TBL] [Abstract][Full Text] [Related]
17. Two-step colocalization of MORC3 with PML nuclear bodies.
Mimura Y; Takahashi K; Kawata K; Akazawa T; Inoue N
J Cell Sci; 2010 Jun; 123(Pt 12):2014-24. PubMed ID: 20501696
[TBL] [Abstract][Full Text] [Related]
18. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells.
Ahn JH; Hayward GS
J Virol; 1997 Jun; 71(6):4599-613. PubMed ID: 9151854
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus immediate-early 1 proteins form a structurally distinct protein class with adaptations determining cross-species barriers.
Schweininger J; Scherer M; Rothemund F; Schilling EM; Wörz S; Stamminger T; Muller YA
PLoS Pathog; 2021 Aug; 17(8):e1009863. PubMed ID: 34370791
[TBL] [Abstract][Full Text] [Related]
20. General blockade of human cytomegalovirus immediate-early mRNA expression in the S/G2 phase by a nuclear, Daxx- and PML-independent mechanism.
Zydek M; Uecker R; Tavalai N; Stamminger T; Hagemeier C; Wiebusch L
J Gen Virol; 2011 Dec; 92(Pt 12):2757-2769. PubMed ID: 21832009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
